chr6-65384473-GT-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001142800.2(EYS):βc.1211delβ(p.Asn404ThrfsTer17) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (β β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes π: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
EYS
NM_001142800.2 frameshift
NM_001142800.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.05
Genes affected
EYS (HGNC:21555): (eyes shut homolog) The product of this gene contains multiple epidermal growth factor (EGF)-like and LamG domains. The protein is expressed in the photoreceptor layer of the retina, and the gene is mutated in autosomal recessive retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 6-65384473-GT-G is Pathogenic according to our data. Variant chr6-65384473-GT-G is described in ClinVar as [Pathogenic]. Clinvar id is 438192.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-65384473-GT-G is described in Lovd as [Pathogenic]. Variant chr6-65384473-GT-G is described in Lovd as [Likely_pathogenic]. Variant chr6-65384473-GT-G is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EYS | NM_001142800.2 | c.1211del | p.Asn404ThrfsTer17 | frameshift_variant | 8/43 | ENST00000503581.6 | NP_001136272.1 | |
EYS | NM_001292009.2 | c.1211del | p.Asn404ThrfsTer17 | frameshift_variant | 8/44 | NP_001278938.1 | ||
EYS | NM_001142801.2 | c.1211del | p.Asn404ThrfsTer17 | frameshift_variant | 8/12 | NP_001136273.1 | ||
EYS | NM_198283.2 | c.1211del | p.Asn404ThrfsTer17 | frameshift_variant | 7/10 | NP_938024.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EYS | ENST00000503581.6 | c.1211del | p.Asn404ThrfsTer17 | frameshift_variant | 8/43 | 5 | NM_001142800.2 | ENSP00000424243 | A2 | |
EYS | ENST00000370621.7 | c.1211del | p.Asn404ThrfsTer17 | frameshift_variant | 8/44 | 1 | ENSP00000359655 | P2 | ||
EYS | ENST00000393380.6 | c.1211del | p.Asn404ThrfsTer17 | frameshift_variant | 8/12 | 1 | ENSP00000377042 | |||
EYS | ENST00000342421.9 | c.1211del | p.Asn404ThrfsTer17 | frameshift_variant | 6/9 | 1 | ENSP00000341818 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1449818Hom.: 0 Cov.: 27 AF XY: 0.00 AC XY: 0AN XY: 722204
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1449818
Hom.:
Cov.:
27
AF XY:
AC XY:
0
AN XY:
722204
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 30, 2021 | ClinVar contains an entry for this variant (Variation ID: 438192). This premature translational stop signal has been observed in individual(s) with clinical features of EYS-related conditions (PMID: 28041643). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Asn404Thrfs*17) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). For these reasons, this variant has been classified as Pathogenic. - |
Retinitis pigmentosa 25 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | May 13, 2022 | - - |
Retinal dystrophy Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | NIHR Bioresource Rare Diseases, University of Cambridge | Jan 01, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at